ATMI Reports First Quarter 2012 Financial Results

Date : 04/25/2012 @ 6:58AM
Source : GlobeNewswire Inc.
Stock : Atmi Inc. (MM) (ATMI)
Quote : 33.98  0.0 (0.00%) @ 2:05AM
Atmi Inc. (MM) share price Chart

ATMI Reports First Quarter 2012 Financial Results

Atmi Inc. (MM) (NASDAQ:ATMI)
Historical Stock Chart

5 Years : From Mar 2013 to Mar 2018

Click Here for more Atmi Inc. (MM) Charts.

ATMI, Inc. (Nasdaq:ATMI) today reported financial results for the first quarter of 2012, which include the effects of the SDS Direct Transaction.

Revenues were $92.6 million for the first quarter of 2012 — including a $2.5 million negative effect from the SDS Direct Transaction — down 8% compared with $100.7 million in the first quarter of 2011. Earnings per diluted share were $0.12, including a $0.04 reduction in earnings per diluted share due to activities associated with the SDS Direct Transaction, compared with earnings per diluted share of $0.25 in the first quarter of 2011.

The attached tables contain a reconciliation of the U.S. GAAP results to the non-GAAP measures for the first quarters of 2012 and 2011, excluding the effect from the SDS Direct Transaction. A table containing segment information also is attached.

"Overall, the first quarter was a bit softer than expected in both our Microelectronics and LifeSciences businesses. On the Microelectronics side, excluding the impact of SDS, the decline in first quarter revenue reflected lower sales of trailing edge technology products resulting principally from slower than expected wafer starts at certain customers, and a decline in sales to the display panel market. In our LifeSciences business, the revenue shortfall was the result of timing issues related to the ramping of new single-use production lines," said Doug Neugold, chairman, chief executive officer and president. "Looking forward we believe wafer starts are increasing and are confident that our Microelectronics business will improve consistent with anticipated growth in wafer starts, as well as from the expected impact of SDS and ramping new product sales. Across the board, we see the strongest demand at technology's leading edge where our customers are producing as many chips as their capacity will allow. Our focus on solving their materials process issues is vitally important to them as they work hard to ramp additional 28-nanometer volume and capacity to meet customer demand."

Neugold continued, "Our SDS Direct integration work and incremental transition spending is rapidly nearing conclusion. With the exception of China, we have moved all of the planned business directly under the ATMI umbrella.  The feedback from customers has been very reinforcing, and we have already initiated collaboration discussions with end users and OEMs focused on improving their processes, validating one of our primary reasons for the deal."

"The Microelectronics industry softness in the quarter was reflected in our results," said Tim Carlson, chief financial officer. "Our Microelectronics revenues were consistent with the industry bottoming during the quarter, particularly with certain foundry customers.  We continued to make additional investments in LifeSciences, to speed product introductions and increase market share, and beginning this quarter, we began reporting segment results, which increases visibility of our LifeSciences activities."

Carlson continued, "We had $2.3 million of SDS integration, transition and operational spending during the quarter and anticipate completing the China business transition during the second quarter.  Once completed, we anticipate incremental revenues of $7 million to $8 million per quarter and $0.08 to $0.09 of incremental quarterly earnings per diluted share as compared to our pre-transaction run-rate."

A conference call (dial-in: 877.766.0748) discussing the Company's financial results and business outlook will begin at 11:00 a.m. Eastern time, April 25, 2012. A replay of the call will be available for 48 hours at 855.859.2056 (access code 41878231). An audio webcast of the conference call will be available for 30 days on

About ATMI

ATMI, Inc. provides specialty semiconductor materials, and high-purity materials handling and delivery solutions designed to increase process efficiencies for the worldwide semiconductor, flat panel, and life sciences industries. For more information, please visit

ATMI, the ATMI logo, and SDS are trademarks or registered trademarks of Advanced Technology Materials, Inc., in the United States, other countries, or both.

The ATMI, Inc. logo is available at

Use of Non-GAAP Measures

ATMI believes that a breakdown, presented on an income statement line-item basis, of how the SDS Direct transaction contributed to the change in net income and other line items is useful to an understanding of the overall change in the consolidated results of operations for ATMI from one reporting period to another. ATMI presents such amounts related to the SDS Direct transaction in a separate column following the dollar amounts shown for the applicable period's results, booked in accordance with generally accepted accounting principles (GAAP), and then by presenting a third column showing the non-GAAP results excluding the effect of the SDS Direct transaction.

Forward Looking Statements

Statements contained herein that relate to ATMI's future performance, including, without limitation, statements with respect to ATMI's anticipated results of operations or level of business for 2012 or any other future period, are forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on current expectations only and are subject to certain risks, uncertainties, and assumptions, including, but not limited to, changes in semiconductor industry growth (including, without limitation, wafer starts) or ATMI's markets; competition, problems, or delays developing, commercializing, and delivering new products; customer-driven pricing pressure; potential loss of key customers; problems or delays in integrating acquired operations and businesses; uncertainty in the credit and financial markets; ability to protect ATMI's proprietary technology; and other factors described in ATMI's Form 10-K for the year ended December 31, 2011 and other subsequent filings with the Securities and Exchange Commission. Such risks and uncertainties may cause actual results to differ materially from those expressed in our forward-looking statements. ATMI undertakes no obligation to update any forward-looking statements.

(in thousands, except per share data)
  Three Months Ended
  March 31,
  2012 2011
Revenues $92,574 $100,724
Cost of revenues 48,392 52,633
Gross profit 44,182 48,091
Operating expenses:    
Research and development 14,489 13,451
Selling, general, & administrative 23,546 22,982
Total operating expenses 38,035 36,433
Operating income 6,147 11,658
Other income, net 19 300
Income before income taxes 6,166 11,958
Provision for income taxes 2,304 3,951
Net income $3,862 $8,007
Earnings per diluted share $0.12 $0.25
Weighted average shares outstanding 32,842 32,384
(in thousands)
  March 31, December 31,
  2012 2011
 Cash & marketable securities (1) $104,531 $110,155
 Accounts receivable, net 54,961 51,563
 Inventories, net 82,418 73,622
 Other current assets 38,156 35,848
 Total current assets 280,066 271,188
 Property, plant, and equipment, net 115,412 116,275
 Marketable securities, non-current (1) 3,329 3,329
 Other assets 122,400 122,894
 Total assets $521,207 $513,686
Liabilities and stockholders' equity    
 Accounts payable $27,426 $20,779
 Other current liabilities 21,833 24,177
 Total current liabilities 49,259 44,956
 Non-current liabilities 19,048 18,399
 Stockholders' equity 452,900 450,331
 Total liabilities & stockholders' equity $521,207 $513,686
(1)  Total cash and marketable securities equaled $107.9 million and $113.5 million at March 31, 2012 and December 31, 2011, respectively.    
Segment Results
(in thousands)
  Revenue Operating income (loss)
  March 31,  March 31, 
  2012 2011 2012 2011
Microelectronics $83,455 $89,901 $21,020 $24,216
LifeSciences 9,109 10,575 (2,126) (459)
All other 10 248 (12,747) (12,099)
Total 92,574 100,724 6,147 11,658
Consolidated Total $92,574 $100,724 $6,147 $11,658
(Non-GAAP Excludes Effects of SDS Direct Transaction)
(in millions, except per share data)*
  US GAAP 2012 SDS Direct 2012 Non-GAAP 2012 US GAAP 2011
Revenues (1) $92.6 ($2.5) $95.1 $100.7
Cost of Revenues (2) $48.4 ($1.3) $49.7 $52.6
Gross Profit $44.2 ($1.2) $45.4 $48.1
% of Revenue 47.7% 48.2% 47.7% 47.7%
Operating Expense (3) $38.0 $1.0 $37.0 $36.4
Operating Profit $6.1 ($2.2) $8.4 $11.7
% of Revenue 6.6%   8.8% 11.6%
Other Income $0.0 $0.0 $0.0 $0.3
Income Taxes $2.3 ($0.8) $3.1 $4.0
Effective Tax Rate (4) 37.4% 36.7% 37.0% 33.0%
Net Income $3.9 ($1.4) $5.3 $8.0
EPS $0.12 ($0.04) $0.16 $0.25
Shares 32.8 32.8 32.8 32.4
(1) $2.5M adjustment for inventory repurchases/burn, net of incremental revenues realized
(2) $1.3M adjustment for cost of inventory associated with repurchased inventory/inventory burn, partially offset by transition service costs and incremental costs on revenues realized
(3) $1.0M of incremental operating expenses
(4) Net tax effect of the items above, at an effective tax rate of 36.7% 
* The table above contains certain immaterial differences in totals, due to effects of rounding
CONTACT: Dan Sharkey,
         Executive Vice President

Latest ATMI Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:30 V:us D:20180320 09:55:54